AFC
GMAB icon

Ares Financial Consulting’s Genmab GMAB Stock Holding History

Ares Financial Consulting’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.97K Hold
363
– – 0.01% 565
2026
Q1 		$9.88K Buy
+363
New +$10.9K 0.01% 550

Other funds holding GMAB

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

Ares Financial Consulting's GMAB Position: Q2 2026 in Review

Ares Financial Consulting held its Genmab (GMAB) position steady in Q2 2026 at 363 shares worth $9.97K. The position accounts for 0.01% of the portfolio, ranked #565.

Ares Financial Consulting first reported a position in GMAB in Q1 2026 and has held it in 2 quarters since. 108 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Ares Financial Consulting held 363 shares of Genmab worth $9.97K as of Q2 2026.
  • Ares Financial Consulting left its Genmab share count unchanged in Q2 2026.
  • Genmab made up 0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #565 holding.
  • Ares Financial Consulting first reported a position in Genmab in Q1 2026 and has held it in 2 quarters since.
  • 108 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.